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Summary
 
Interleukin (IL)-12 is a monocyte- and macrophage-derived cytokine that plays a crucial role
in both the innate and the acquired immune response. In this study, we examined the effects
that ligating specific macrophage receptors had on the induction of IL-12 by lipopolysaccharide
(LPS). We report that ligation of the macrophage Fc
 
g
 
, complement, or scavenger receptors in-
hibited the induction of IL-12 by LPS. Both mRNA synthesis and protein secretion were di-
minished to near-undetectable levels following receptor ligation. Suppression was specific to
IL-12 since IL-10 and tumor necrosis factor-
 
a
 
 (TNF-
 
a
 
) production were not inhibited by li-
gating macrophage receptors. The results of several different experimental approaches suggest
that IL-12 downregulation was due to extracellular calcium influxes that resulted from receptor
ligation. First, preventing extracellular calcium influxes, by performing the assays in EGTA, ab-
rogated Fc
 
g
 
R-mediated IL-12(p40) mRNA suppression. Second, exposure of macrophages to
the calcium ionophores, ionomycin or A23187, mimicked receptor ligation and inhibited
IL-12(p40) mRNA induction by LPS. Finally, bone marrow–derived macrophages from FcR
 
g
 
 chain–deficient mice, which fail to flux calcium after receptor ligation, failed to inhibit IL-12(p40)
mRNA induction. These results indicate that the calcium influxes that occur as a result of re-
ceptor ligation are responsible for inhibiting the induction of IL-12 by LPS. Hence, the ligation of
phagocytic receptors on macrophages can lead to a dramatic decrease in IL-12 induction. This
downregulation may be a way of limiting proinflammatory responses of macrophages to extra-
cellular pathogens, or suppressing the development of cell-mediated immunity to intracellular
pathogens.
 
T
 
he role of IL-12 in the induction of an acquired cellu-
lar immune response has been well documented (1).
IL-12 is required for the development of a Th1-type im-
mune response (2–4). This cytokine is a potent inducer of
IFN-
 
g
 
 from T cells and NK cells (5-7). Both in vitro and
in vivo experiments have demonstrated that IL-12 plays a
crucial role in the development of specific immunity against a
number of intracellular pathogens, including 
 
Leishmania ma-
jor
 
, 
 
Mycobacterium tuberculosis
 
, 
 
Listeria monocytogenes
 
, and 
 
Toxo-
plasma gondii
 
 (2, 8–12). Animals lacking the IL-12 gene (13)
or animals treated with antibodies to IL-12 (9, 14, 15) are
invariably more susceptible to infections with these intra-
cellular pathogens. IL-12 has also been shown to have ad-
juvant properties, stimulating an effective cellular immune
response to microbial antigens that are not appropriately
immunogenic when administered alone (16, 17). The over-
production of IL-12 (during an immune response) how-
ever, has the potential to be detrimental to the host. IL-12
produced during LPS endotoxemia, and during a number
of autoimmune disorders, including insulin-dependent dia-
betes mellitus (18), experimental allergic encephalomyelitis
(19), or collagen-induced arthritis (20), can lead to exacer-
bated disease.
Because of the central role that IL-12 plays in modulat-
ing the immune response, it is critical to understand the
mechanisms involved in the regulation of IL-12 biosynthe-
sis. Biologically active IL-12 is a 70-kD heterodimer (p70)
composed of two subunits, p35 and p40 (6, 21). IL-12 pro-
duction can be induced by exposing macrophages to a vari-
ety of microbial products, including LPS, lipoteichoic acid,
protein extracts, and heat-shock proteins (7, 22, 23). The
induction of IL-12 p40 mRNA is highly regulated and is
expressed only by cell types that produce biologically active
IL-12. IL-12 secretion by macrophages can be up- or
downregulated by other cytokines. Priming phagocytic cells
with IFN-
 
g
 
 or GM-CSF, for example, can enhance their
ability to produce IL-12 (24–26), whereas IL-4, IL-10, IL-13,
and TGF-
 
b
 
 can suppress IL-12 production (27, 28). It has
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been recently demonstrated that some microbes can also in-
fluence IL-12 production by macrophages. 
 
L. major
 
, measles
virus, and HIV have all been shown to downregulate the
production of IL-12 by macrophages or monocytes in-
fected with them (29–32). This downmodulation of IL-12
has the potential of providing these pathogens with a means
of suppressing the development of cell-mediated immunity.
In this report, we show that ligation of Fc
 
g
 
, comple-
ment, or scavenger receptors on macrophages can lead to
the selective suppression of IL-12 production by macro-
phages. We implicate calcium fluxes in IL-12 downmodu-
lation. This cytokine downmodulation after receptor liga-
tion may contribute to the transient nature of IL-12 in
plasma during bacteremia, and it may result in diminished
IL-12 production in an immune host due to the rapid
clearance of IgG-opsonized bacteria. The receptor-medi-
ated inhibition of IL-12 induction may also be exploited by
intracellular pathogens of macrophages to downmodulate
IL-12 production and suppress or delay the development of
cell-mediated immunity.
 
Materials and Methods
 
Macrophages.
 
6–8-wk-old female BALB/c and C57BL/6
mice were obtained from Taconic (Germantown, NY). FcR 
 
g
 
chain 
 
2
 
/
 
2
 
 mice were generously provided by Dr. Jeffrey Ra-
vetch (Rockefeller University, NY) and were generated as previ-
ously described (33). Bone marrow–derived macrophages (BMM
 
f
 
)
 
1
 
were established as previously described (34), with minor modifi-
cations. In brief, femurs were flushed with cation-free Dulbecco’s
PBS, using a 23-gauge needle. Cells were grown in DMEM con-
taining 20% L929 cell-conditioned medium, 10% heat-inacti-
vated (HI)-FCS, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin G, and
100 
 
m
 
g/ml streptomycin. Cells were incubated at 37
 
8
 
C in 5%
CO
 
2
 
 for 5–7 d until uniform monolayers of macrophages were
established. 12 h before use, cells were removed from the original
plastic petri dishes by EDTA and a total of 1 
 
3
 
 10
 
6
 
 cells were
plated per well of tissue culture-treated six-well plates (Nunc,
Naperville, IL) in DMEM containing 10% HI-FCS, 2 mM
 
l
 
-glutamine, 100 U/ml penicillin G, and 100 
 
m
 
g/ml streptomy-
cin (complete medium). Murine resident peritoneal macrophages
were washed from the peritoneal cavity of BALB/c mice with
cold cation-free Dulbecco’s PBS. The cells were resuspended in
complete medium and plated at 5 
 
3
 
 10
 
6
 
 cells/well of tissue cul-
ture-treated six-well plates. The cells were allowed to adhere for
1 h at 37
 
8
 
C, washed with DMEM, and incubated for a further 3 h
in DMEM containing 10% HI-FCS and 2 mM 
 
l
 
-glutamine.
 
Opsonized Erythrocytes.
 
IgG-opsonized erythrocytes (E-IgG)
were generated by incubating SRBC (Lampire, Pipersville, PA)
with rabbit anti-SRBC IgG (Cappel, Durham, NC) at nonagglu-
tinating titers for 40 min at room temperature. E-IgG were
washed with HBSS (GIBCO BRL, Gaithersburg, MD) and re-
suspended at 4 
 
3
 
 10
 
8
 
 cells/ml. Complement-opsonized erythro-
cytes (E-C3bi) were generated by incubating SRBC with culture
supernatant of hybridoma S-S.3 (anti-SRBC IgM/
 
k
 
; American
Type Culture Collection, Rockville, MD) at nonagglutinating ti-
ters for 40 min at room temperature. IgM-opsonized erythrocytes
were washed twice with HBSS and resuspended at 1 
 
3
 
 10
 
8
 
 cells/ml
in HBSS with 10% murine C5-deficient serum. After a 15-min
incubation at 37
 
8
 
C, E-C3bi were washed once with HBSS and
resuspended at 4 
 
3
 
 10
 
8
 
 cells/ml. Maleylated-BSA (mBSA)-coated
erythrocytes (E-ML-BSA) were generated as follows. Maleylation
of BSA was performed as described (35). 2-iminothiolane (Pierce,
Rockford, IL) was used to introduce sulfhydryl residues into
mBSA according to the manufacturer’s instructions. In brief,
mBSA (4.5 mg/ml) was incubated with 0.3 mM 2-iminothiolane
in PBS with 1 mM EDTA, pH 8.0, for 45 min at room tempera-
ture. Unreacted 2-iminothiolane was separated by using size-frac-
tionation chromatography with a PD-10 column (Pharmacia, Pis-
cataway, NJ). mBSA containing sulfhydryl groups (mBSA-SH)
was coupled to SRBC using a modification of a method described
previously (36). Sulfosuccinimidyl-4-(
 
N
 
-maleimidomethyl)-cyclo-
hexane-1-carboxylate (sulfo-SMCC [Pierce]), at a final concentra-
tion of 0.5 mM, was incubated with SRBC (1 
 
3
 
 10
 
9
 
 cells/ml) in
HBSS for 60 min at room temperature with continuous rotation.
The thiol-activated SRBC were washed four times with HBSS,
resuspended in mBSA-SH (4 mg/ml) to a concentration of 5 
 
3
 
10
 
9
 
 cells/ml, and incubated at room temperature with continuous
rotation for 60 min. The resulting E-ML-BSA were washed three
times with HBSS and resuspended to a concentration of 4 
 
3
 
 10
 
8
 
cells/ml.
 
Macrophage Stimulation and Receptor Ligation.
 
BMM
 
f
 
 monolayers
were washed once with complete medium. After washing, stim-
uli were added at the following concentrations: opsonized eryth-
rocytes were added at a ratio of 20 erythrocytes per macrophage,
2.0 
 
m
 
m latex microspheres (Duke Scientific, Palo Alto, CA) were
added at a ratio of 40 microspheres per macrophage, the cal-
cium ionophores ionomycin (Calbiochem Novabiochem, La
Jolla, CA) and A23187 (Calbiochem Novabiochem) were added
to final concentrations of 5 and 10 
 
m
 
M, respectively. All stimuli
were either added alone or simultaneously with LPS (
 
Escherichia coli
 
0127:B8 [Sigma Chem. Co., St. Louis, MO]) at a final concentra-
tion of 50 ng/ml. Unless otherwise stated, RNA was extracted from
BMM
 
f
 
 monolayers 6 h later, using RNAzol B (Tel-Test, Friends-
wood, TX). Antibody cross-linking of BMM
 
f
 
 receptors was per-
formed as follows. BMM
 
f
 
 monolayers were washed once with
complete medium and then antibodies M1/70 (anti-murine Mac-1;
ATCC), or 2.4G2 (anti-murine CD16/CD32; PharMingen, San
Diego, CA) were added at a final concentration of 10 
 
m
 
g/ml.
BMM
 
f
 
 monolayers were then incubated at 37
 
8
 
C for 15 min, fol-
lowed by one wash with complete medium. Goat anti–rat IgG
F(ab
 
9
 
)
 
2
 
 (Jackson ImmunoResearch, West Grove, PA) at a final
concentration of 50 
 
m
 
g/ml was then added to the wells simulta-
neously with LPS at a final concentration of 50 ng/ml. BMM
 
f
 
monolayers were incubated for a further 6 h at 37
 
8
 
C, following
which RNA was extracted from BMM
 
f
 
 using RNAzol B.
 
ELISA for IL-12.
 
BMM
 
f
 
 were stimulated as described above,
and then placed into culture for an additional 24 h, at which time
IL-12 levels in cell supernatants were assayed. Murine IL-12 p70
was measured by an ELISA specific for the p70 heterodimer
(Genzyme, Cambridge, MA) according to the manufacturer’s di-
rections. The mean of triplicate wells were calculated based on a
standard curve that was constructed for each assay, using recom-
binant murine IL-12(p70) (Genzyme).
 
Bacterial Infection of Macrophages.
 
The 
 
Eagan
 
 clinical isolate of
type-b 
 
H. influenzae
 
 has been previously described and character-
ized (37). Organisms were grown for 3 h at 37
 
8
 
C in brain–heart
 
1
 
Abbreviations used in this paper:
 
 BMM
 
f
 
, bone marrow–derived macro-
phages; E-C3bi, complement-opsonized erythrocytes; E-IgG, IgG-opsonized
erythrocytes; E-ML-BSA, maleylated-BSA–coated erythrocytes; HI, heat-
inactivated; HPRT, hypoxanthine-guanine phosphoribosyltransferase;
mBSA, maleylated-BSA. 
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infusion broth (Difco, Detroit, MI) supplemented with NAD and
hemin and then washed twice in HBSS. Bacteria were opsonized
by incubation with anti-
 
H. influenzae
 
 poly-serotype antiserum
(Difco) at a 1:25 dilution for 15 min at room temperature. IgG-
opsonized or unopsonized bacteria were added to monolayers of
peritoneal macrophages, at a ratio of 130 bacteria per macrophage,
either alone or simultaneously with LPS (50 ng/ml). Three h
later RNA was extracted from macrophage monolayers, using
RNAzol B.
 
Competitive Quantitative RT-PCR.
 
Total RNA was extracted
using RNAzol B according to the manufacturer’s instructions.
1–3 
 
m
 
g of RNA was reverse transcribed using Superscript II RT
(GIBCO BRL) and random hexamer primers (Promega, Madison,
WI). PCR was performed using a multiple cytokine-containing
competitor PQRS (38), generously provided by Dr. Steven Reiner
(University of Chicago, Chicago, IL). Sample cDNAs were first
assayed for the levels of the constitutively expressed gene hypox-
anthine-guanine phoshphoribosyltransferase (HPRT), using equal
concentrations of competitor construct in each reaction. Input
cDNA volumes were then adjusted, using a fixed competitor
concentration in all reactions, in order to standardize the HPRT
level to comparable levels among all groups. The HPRT-normal-
ized cDNAs were then used to quantitate cytokine level, using
cytokine-specific primers and a fixed concentration of competitor
construct in each reaction. The primers used for amplification
were as follows (38): HPRT, 5
 
9
 
-GTTGGATACAGGCCAGAC-
TTTGTTG, 3
 
9
 
-GAGGGTAGGCTGGCCTATAGGCT; IL-12
(p40), 5
 
9
 
-ATGGCCATGTGGGAGCTGGAGAAAG, 3
 
9
 
-GTG-
GAGCAGCAGATGTGAGTGGCT; IL-10, 5
 
9
 
-CCAGTTTTA-
CCTGGTAGAAGTGATG, 3
 
9
 
-TGTCTAGGTCCTGGAGTC-
CAGCAGACTCAA; TNF-
 
a
 
, 5
 
9
 
-GTTCTATGGCCCAGAC-
CCTCACA, 3
 
9
 
-TACCAGGGTTTGAGCTCAGC. cDNA was
amplified for 35 cycles (94
 
8
 
C for 40 s, 60
 
8
 
C for 20 s, 72
 
8
 
C for 40 s,
and a final extension at 72
 
8
 
C for 10 min), using Taq polymerase
(Boehringer Mannheim, Indianapolis, IN). Amplification prod-
ucts were resolved on 2.0% ethidium-stained agarose gels.
 
Calcium Flux Measurements.
 
BMM
 
f
 
 were suspended at a con-
centration of 2 
 
3
 
 10
 
6
 
 cell/ml in DMEM with 10% HI-FCS with
2 
 
m
 
M fura-2/AM (Molecular Probes Inc., Eugene, OR) for 30
min at 35
 
8
 
C. Fura-2/AM loaded cells were incubated with mAb
2.4G2 (5 
 
m
 
g/ml) for 30 min at 4
 
8
 
C. Relative fluorescence was
monitored in a Perkin-Elmer fluorimeter (Emeryville, CA). Cells
were stimulated with goat anti–rat IgG mAb (Cappel) at 25 ng/ml.
 
Results
 
Effect of Specific Receptor Ligation on the Induction of Macro-
phage IL-12(p40) mRNA.
 
Cytokine production by BMM
 
f
 
following their incubation with particulate ligands was ex-
amined. The particulate ligands used in this study were
erythrocytes opsonized with IgG or complement, or eryth-
rocytes to which maleylated-BSA was covalently attached.
These particles specifically ligate Fc
 
g
 
, complement, or
scavenger receptors, respectively. The receptor specificity
of each of these particles was shown by inhibiting their ad-
hesion to macrophages with receptor-specific mAbs or
competitive ligands (data not shown). The ligation of
Fc
 
g
 
, complement, or scavenger receptors by these particles
failed to induce the production of IL-12(p40) mRNA by
macrophages (Fig. 1). Even in the absence of competitor,
no IL-12(p40) PCR product was detected after exposure of
macrophages to any of these particles (data not shown).
The phagocytosis of latex microspheres by macrophages
also failed to induce IL-12(p40) mRNA. Thus, neither the
phagocytosis of latex beads nor the ligation of one of the
macrophage phagocytic receptors was sufficient to induce
the production of IL-12 by macrophages. The potent in-
ducer of IL-12, IFN-
 
g
 
 and LPS, was used as a positive con-
trol for these studies (Fig. 1).
 
Selective Suppression of IL-12(p40) mRNA Induction after
Specific Receptor Ligation.  BMMf from BALB/c mice were
incubated for 6 h with either LPS alone or simultaneously
with LPS and particulate ligands (Fig. 2 A). LPS was a po-
tent inducer of IL-12(p40), IL-10, and TNF-a mRNA.
The ligation of Fcg, complement, or scavenger receptors si-
multaneously with the addition of LPS markedly inhibited
the induction of IL-12(p40) mRNA. The phagocytosis of
latex microspheres also inhibited IL-12 mRNA induction,
but to a much lesser extent. The suppression of cytokine
mRNA induction by receptor ligation was specific to IL-12,
and not due to a generalized failure of macrophage func-
tion, since the induction of IL-10 and TNF-a mRNA were
not inhibited by receptor ligation. In fact, IL-10 mRNA levels
from BMMf incubated with LPS and E-IgG were slightly
elevated compared to those from BMMf incubated with
LPS alone (Fig. 2 A). Quantitative RT-PCR was per-
formed to determine the degree of reduction of IL-12(p40)
mRNA caused by FcgR ligation. Ligation of macrophage
FcgR resulted in a 100–200-fold reduction in the amount of
IL-12(p40) mRNA induced in response to LPS (Fig. 2 B).
Effect of Antibody Cross-linking of FcgRII/RIII and Mac-1 on
LPS-mediated IL-12(p40) mRNA Induction. To further ex-
amine the roles of specific receptor ligation on the inhibi-
tion of IL-12(p40) mRNA induction, mAbs were used to
cross-link specific macrophage receptor classes. BMMf
from BALB/c mice were incubated for 15 min with mAbs
against either FcgRII/RIII or Mac-1. Cells were then
treated simultaneously with LPS and anti-rat IgG F(ab9)2 in
order to cross-link the receptors. 6 h later, cytokine mRNA
levels were assessed (Fig. 3). Cross-linking of FcgRII/RIII
or Mac-1 resulted in the suppression of LPS-mediated
IL-12(p40) mRNA induction. The induction of IL-10 and
Figure 1. Effect of specific re-
ceptor ligation on IL-12(p40)
mRNA production by BMMf.
BMMf from BALB/c mice
were exposed to either IFN-g
and LPS (100 U/ml and 50 ng/ml,
respectively), or erythrocytes op-
sonized with IgG (E-IgG), C3bi
(E-C3bi), or maleylated BSA
(E-ML-BSA), or latex micro-
spheres, as indicated. 6 h after the addition of stimuli, total RNA was iso-
lated and used to carry out competitive RT-PCR. The ratio of the inten-
sity of competitor (upper band in each reaction) to wild-type (lower band
in each reaction) for the amplification reaction was used to determine
cDNA levels. cDNA was resolved on a 2% ethidium-stained agarose gel
and normalized for HPRT intensities. The normalized cDNAs were then
used in subsequent PCR reactions, using primers for the inducible p40
subunit of IL-12.1980 Receptor-mediated Inhibition of IL-12 Production
TNF-a mRNA, in contrast, was not inhibited by receptor
cross-linking. In fact, IL-10 mRNA levels for FcgRII/RIII
cross-linked cells were even slightly elevated.
IL-12 Secretion by Macrophages after Receptor Ligation.
The secretion of the IL-12 p70 heterodimeric protein by
macrophages was measured by an ELISA specific for p70.
BMMf produced only modest amounts of IL-12(p70)
when incubated with LPS alone. This production of IL-12
was reduced to near baseline levels by coincubating the
monolayers with erythrocytes opsonized with IgG or iC3b
(Fig. 4, inset). The priming of macrophages with IFNg for
8 h before the addition of LPS increased IL-12(p70) produc-
tion dramatically, as previously described (25, 26). IL-12
production by IFNg-primed macrophages was also signifi-
cantly inhibited by coincubating the monolayers with eryth-
rocytes opsonized with IgG or iC3b (Fig. 4). The inhibition
of IL-12 secretion was specific to IL-12 because IL-10 pro-
duction, measured by a similar ELISA performed on the
same supernatants at 24 h, was not reduced by the addition
of opsonized erythrocytes (data not shown).
Figure 2. Effect of specific re-
ceptor ligation on the LPS-
induced expression of cytokine
mRNA. (A) BMMf from
BALB/c mice were exposed to
LPS (50 ng/ml), or LPS in combi-
nation with either E-IgG, E-C3bi,
E-ML-BSA, or latex micro-
spheres. 6 h after the addition of
stimuli, total RNA was isolated
and used to carry out competi-
tive RT-PCR, using primers for
HPRT, TNF-a, IL-10, or the
inducible p40 subunit of IL-12, as
described in Materials and Meth-
ods. (B) cDNA generated from
BALB/c BMMf exposed to
LPS (50 ng/ml) or LPS in com-
bination with E-IgG, were first
normalized for HPRT levels. Constant volumes of normalized cDNAs were then amplified in the presence of decreasing concentrations of competitor
(PQRS), using primers for the inducible p40 subunit of IL-12. The concentration of the experimental cDNA is represented by the equivalent intensities
of competitor and wild-type bands. The fold decrease in IL-12(p40) levels between BMMf exposed to LPS or LPS in combination with E-IgG can be
determined by taking the ratio of their equivalence points.
Figure 3. Effect of antibody
cross-linking of BMMf recep-
tors on the LPS-induced expres-
sion of cytokine mRNA.
BMMf from BALB/c mice
were incubated with the mAb
M1/70 (anti–Mac-1) or mAb
2.4G2 (anti-CD16/32) for 15
min. After one wash with com-
plete medium, LPS (50 ng/ml)
was added to all wells. Goat anti-rat
IgG F(ab9)2 was added simulta-
neously with the LPS to mAb-
treated wells. 6 h after the addition
of stimuli, total RNA was iso-
lated and used to carry out com-
petitive RT-PCR, using primers
for HPRT, TNF-a, IL-10, or
the inducible p40 subunit of IL-12,
as described in detail in Materials
and Methods. Results are repre-
sentative of two separate experi-
ments.
Figure 4. ELISA for IL-12. BMMf from BALB/c mice that were either
primed with IFN-g (100 U/ml) for 8 h or left unprimed were stimulated
with LPS alone or LPS in combination with E-IgG or E-C3bi. After 24 h the
supernatant was harvested and IL-12 p70 levels were determined by ELISA.
Unstimulated cells were cultured in parallel without LPS or erythrocytes.
Determinations were performed in triplicate and expressed as the mean 6
SD. Results are representative of two separate experiments. First four
lanes are repeated in the inset.1981 Sutterwala et al.
Role of Calcium in the Inhibition of LPS-induced IL-12(p40)
mRNA. To examine the role of extracellular calcium in
the downregulation of IL-12 production, the calcium che-
lator EGTA was employed. BMMf from BALB/c mice
were stimulated with LPS in the presence or absence of
5 mM EGTA (Fig. 5). LPS induced high levels of IL-12(p40)
mRNA by BMMf cultured in either calcium-containing or
calcium-free medium, indicating that extracellular calcium
is not needed for the induction of IL-12(p40) mRNA by
LPS. As expected, the addition of E-IgG to LPS-treated mac-
rophages in calcium-containing medium showed a drama-
tic inhibition in IL-12(p40) mRNA induction (Fig. 5).
Ligation of FcgR in the absence of extracellular calcium,
however, showed a complete abrogation of FcgR-medi-
ated suppression of IL-12(p40) mRNA induction (Fig. 5).
These data suggest that calcium influxes, which occur as a
result of receptor ligation, are responsible for the dimin-
ished IL-12 induction that we observed. To examine fur-
ther the role of calcium in this phenomenon, BMMf were
incubated for 3 h with LPS and the calcium ionophores,
ionomycin or A23187. Ionomycin, and to a lesser extent
A23187, caused a suppression of LPS-mediated IL-12(p40)
mRNA induction (Fig. 6). This suppression was specific to
IL-12, since the ionophores did not affect IL-10 mRNA
levels induced by LPS. These results indicate that iono-
phore-mediated calcium influxes can mimic receptor liga-
tion and specifically inhibit IL-12(p40) mRNA induction.
BMMf From FcR g Chain–deficient Mice Are Incapable of
FcgR-mediated Suppression of IL-12(p40) mRNA Induction.
We next examined IL-12 production in BMMf from FcR
g2/2 mice. Macrophages from these mice bind IgG-opso-
nized erythrocytes normally (data not shown) but lack the
ability to efficiently phagocytose IgG-opsonized erythro-
cytes (33). The deletion of the FcR g chain profoundly im-
pairs signaling through the FcgR (33). Unlike wild-type
cells, which rapidly flux calcium upon FcgR ligation,
BMMf from FcR g2/2 mice fail to cause calcium fluxes
following FcgR ligation (Fig. 7 A). Macrophages from
normal and FcR g2/2 mice were incubated in LPS alone
or with LPS and E-IgG (Fig. 7 B). Both C57BL/6 and FcR
g2/2 BMMf expressed IL-12(p40) mRNA after LPS
treatment. As expected, ligation of FcgR on C57BL/6
BMMf resulted in a marked suppression of LPS-mediated
IL-12(p40) mRNA induction. However, the ligation of
FcgR on g2/2 BMMf did not inhibit the induction of
IL-12(p40) mRNA by LPS. These results correlate signal-
ing through the FcgR with the downregulation of IL-12
production after receptor ligation.
Bacterial Infection and IL-12(p40) mRNA Induction. To ex-
amine the effect of bacterial phagocytosis on IL-12 produc-
tion in vitro, type-b H. influenzae was added to macrophage
monolayers. Previous studies have demonstrated that type-b
H. influenzae bind very poorly to macrophages in vitro, un-
less an opsonin such as IgG or complement, is added to the
assay (37). Despite this poor binding, unopsonized H. influ-
enzae readily induced macrophage IL-12(p40) mRNA pro-
duction. In contrast, the addition of an equal amount of
IgG-opsonized bacteria, which bound avidly to macrophages,
induced only modest amounts of IL-12(p40) mRNA (Fig.
8, left). Opsonized or unopsonized bacteria were also added
to macrophages in the presence of LPS (Fig. 8, right). Simi-
lar to previous experiments, the addition of LPS to macro-
Figure 5. FcgR ligation in the
presence of EGTA. BMMf from
BALB/c mice were incubated for 3 h
with LPS alone or with LPS and
E-IgG in either complete medium
(lanes 1 and 2) or in calcium-free
S-MEM containing 5 mM EGTA
(lanes  3 and 4). After the incubation,
total RNA was isolated and used to
carry out competitive RT-PCR as
described in detail in Materials and
Methods. Results are representative
of two separate experiments. 
Figure 6. The suppression of
LPS-induced IL-12(p40) mRNA by
calcium ionophores. BMMf from
BALB/c mice were incubated for 3 h
with either LPS alone or LPS in com-
bination with either ionomycin (5
mM), A23187 (10 mM), or E-IgG.
Total RNA was isolated and used to
carry out competitive RT-PCR as
described in Materials and Methods.
Results are representative of two
separate experiments.
Figure 7. FcgR ligation on BMMf from FcR g2/2 mice. (A)
BMMf were preincubated with mAb 2.4G2 before stimulation with the
secondary antibody, goat anti–rat IgG mAb. Relative fluorescence indica-
tive of intracellular Ca21 is shown for wild-type cells (C57BL/6) and FcR
g2/2 cells. (B) BMMf from FcR g2/2 or C57BL/6 mice were ex-
posed to LPS alone or LPS in combination with E-IgG. 6 h after the ad-
dition of stimuli, total RNA was isolated and used to carry out competi-
tive RT-PCR, using primers for HPRT, or the inducible p40 subunit of
IL-12, as described in Materials and Methods. Results are representative
of three separate experiments.1982 Receptor-mediated Inhibition of IL-12 Production
phage monolayers induced the production of IL-12(p40)
mRNA. The simultaneous addition of unopsonized H. in-
fluenzae to monolayers increased IL-12 production by mac-
rophages. However, the addition of LPS and IgG-opsonized
bacteria resulted in an inhibition of IL-12(p40) mRNA
production by macrophages to levels below that induced
by LPS alone. Thus, the phagocytosis of IgG-opsonized
bacteria by macrophages actually diminished the produc-
tion of IL-12 made in response to LPS.
Discussion
Due to its proinflammatory and immunoregulatory ac-
tivity, IL-12 has been considered to be a cytokine which
bridges innate and acquired immunity (1). In models of acute
bacterial infection, IL-12 appears rapidly in the plasma and
peaks within 3 h (39). Experimental animals lacking IL-12
have impaired bacterial clearance and succumb more easily
to acute bacterial infections (40). The mechanisms whereby
this initial IL-12 response contributes to our innate resis-
tance to acute bacterial infections is a matter of ongoing in-
vestigation. In the acquired immune response, IL-12 can
play an immunoregulatory role. It is required for the devel-
opment of a Th1-like immune response, which has been
shown to be critical to host defense against a variety of in-
tracellular pathogens. Despite the importance of this cyto-
kine to both innate and acquired immunity, several aspects
of the control of IL-12 production remain unknown.
The phagocytosis of a number of microbial pathogens,
including Gram-positive and -negative bacteria, several in-
tracellular protozoa, and fungi has been associated with
IL-12 production by macrophages. The implication from
these studies was that receptor-mediated phagocytosis may
be a biologically important trigger for IL-12 production.
The phagocytosis of latex beads, however, did not induce
IL-12 production (41), suggesting that the process of phago-
cytosis, alone, was not sufficient to induce the production
of IL-12. We developed particles which interact specifically
with phagocytic receptors on macrophages. None of the
particles used in our work was sufficient to induced IL-12
production by macrophages (Fig. 1). Thus, receptor-medi-
ated endocytosis is not, itself, the trigger for macrophage
IL-12 production. Furthermore, when macrophages were
exposed to these particles and stimulated with LPS, there
was a substantial decrease in IL-12 production. The degree
of this inhibition of IL-12 induction was dramatic and in
some cases, such as with FcgR ligation, IL-12 production
was reduced to near background (unstimulated) levels. This
reduction in IL-12 biosynthesis was observed at both the
protein and the mRNA levels.
There were several degrees of specificity to this dimin-
ished induction of IL-12. First, the reduction was specific
to IL-12, in that two other cytokines that are induced by
LPS, TNF-a, and IL-10 were not diminished by receptor
ligation. Second, antibodies to phagocytic receptors could
mimic particulate ligation and prevent IL-12(p40) mRNA
induction, but antibodies to CD14 did not alter IL-12(p40)
induction (data not shown). Finally, the diminished pro-
duction of IL-12 which occurred in response to receptor-
specific ligation occurred only minimally after the phago-
cytosis of latex beads. Thus, the inhibition of induction of
IL-12 after macrophage receptor ligation exhibited speci-
ficity with regard to the cytokines that were regulated, the
receptors that could mediate this effect, and the mechanism
of particle uptake.
To determine the mechanism of the inhibition of IL-12
induction, macrophages were exposed to ligands and stim-
ulated with LPS under various experimental conditions.
Treatment of monolayers with cytochalasin B, genestein or
cycloheximide prior to their stimulation did not affect the
inhibition of IL-12 production (data not shown). Thus, the
inhibitory effect of receptor ligation on IL-12 production
was not dependent on particle internalization, genestein-
inhibitable protein phosphorylation or protein synthesis.
The insensitivity to cycloheximide indicates that the inhi-
bition of IL-12 production was not dependent on the syn-
thesis of potentially inhibitory cytokines, such as IL-10.
However, it was dependent on fluxing calcium from extra-
cellular sources. The inhibition of IL-12 induction only
occurred when the assays were performed in medium con-
taining calcium. Additionally, the calcium ionophores, iono-
mycin and A23187, could each mimic receptor ligation and
diminish IL-12 production independent of receptor liga-
tion. Finally, macrophages from FcR g chain–deficient
mice, which failed to flux calcium upon FcgR ligation,
also failed to inhibit IL-12(p40) mRNA induction. Thus,
the effects that we have observed are dependent on recep-
tor ligation that causes a calcium influx and results in the
diminished induction of IL-12.
The biological relevance of these observations awaits ad-
ditional study, but several aspects regarding the control of
IL-12 biosynthesis have begun to emerge. First, not only is
phagocytosis not the primary trigger for IL-12 production,
but phagocytic receptor ligation may be an important down-
modulator of IL-12. When macrophages were exposed to
LPS they made large amounts of IL-12(p40) mRNA and
protein. The addition of opsonized particles, including type b
H. influenzae, to these monolayers significantly diminished
IL-12 production. Thus, receptor-mediated endocytosis may
modulate the production of IL-12 during acute bacterial
infections. The clearance of extracellular bacteria by macro-
Figure 8. IL-12(p40) mRNA
induction by macrophages after
infection with bacteria. Perito-
neal macrophages from BALB/c
mice were incubated for 3 h with
equal numbers of either unop-
sonized or IgG-opsonized H. in-
fluenzae (left). Parallel monolayers
were also incubated with LPS and
equal amounts of either unop-
sonized or IgG-opsonized H. in-
fluenzae ( right). Total RNA was
isolated and used to carry out com-
petitive RT-PCR as described in
Materials and Methods.1983 Sutterwala et al.
phages may contribute to the cessation of IL-12 production,
thereby accounting for the transient nature of the initial
IL-12 peak observed during bacterial infections. Further-
more, in immune individuals, bacterial clearance via Fcg
and complement receptors may prevent the production of
IL-12, thereby promoting the continued development of a
Th2-like immune response and preventing the production
of Th1 cytokines. This may represent another way of bias-
ing the immune response toward humoral immunity and
away from cellular immunity.
The downmodulation of IL-12 production by macro-
phages after receptor ligation may be exploited by intracel-
lular pathogens of macrophages. It has previously been re-
ported that the interaction of Leishmania (29), measles virus
(30), and HIV (31, 32) with macrophages and monocytes
can cause a decrease in IL-12 production by these cells. In
all three cases, it was postulated that this downregulation of
IL-12 may influence the development of cell-mediated im-
munity to these pathogens. From these studies, it was not
clear whether microbial-derived factors (29) or specific cel-
lular receptor ligation (30) or both were responsible for cy-
tokine downmodulation. We would hypothesize that the
downregulation of IL-12 by intracellular pathogens is pri-
marily due to the mechanism by which they interact with
macrophages (30). In all of these studies, the decrease in
IL-12 production that was observed may have been the re-
sult of macrophage receptor ligation which resulted in cal-
cium fluxes.
In summary, these studies demonstrate that ligation of
phagocytic receptors on macrophages can downmodulate
IL-12 production. This downmodulation can potentially
influence the development of immunity to both extracellu-
lar and intracellular pathogens. In an immune host, the
clearance of extracellular bacteria that are opsonized with
immunoglobulin or complement may inhibit the develop-
ment of an inappropriate cell-mediated immune response
by suppressing IL-12 production. Conversely, intracellular
pathogens of macrophages can exploit this receptor-medi-
ated suppression of IL-12 in order to evade a cell-mediated
immune response. Finally, these observations may have ther-
apeutic implications for the development of anti-inflamma-
tory agents to limit IL-12 production. Studies to determine
the potential nonspecific anti-inflammatory effects of cross-
linking monocyte receptors are currently underway.
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